Xiao Y, Hu Y, Lv X, Huang L, Geng L, Liao P
Reprod Biol Endocrinol. 2024; 22(1):78.
PMID: 38987797
PMC: 11234746.
DOI: 10.1186/s12958-024-01251-5.
Ghiasi Hafezi S, Ghorbanzadeh M, Honarmand Rahaghi B, Rezvaniyan F, Forghani N, Shafiean M
Int J Fertil Steril. 2024; 18(3):222-227.
PMID: 38973274
PMC: 11245587.
DOI: 10.22074/ijfs.2023.1988282.1428.
Aktas G, Bertizlioglu M, Yilmaz S, Kebapcilar A, Celik C, Secilmis O
Cureus. 2024; 16(5):e60446.
PMID: 38883018
PMC: 11179686.
DOI: 10.7759/cureus.60446.
Tu W, Zhang W, Wang H, Zhang Y, Huang J, Li B
Front Vet Sci. 2023; 10:1231833.
PMID: 37565082
PMC: 10410075.
DOI: 10.3389/fvets.2023.1231833.
Karacin P, Dilbaz S, Aldemir O, Dilbaz B, Ustun Y
J Hum Reprod Sci. 2023; 16(1):57-63.
PMID: 37305769
PMC: 10256938.
DOI: 10.4103/jhrs.jhrs_17_23.
Effects of follicular output rate on cumulative clinical pregnancy rate and cumulative live birth rate in PCOS patients with different characteristics.
Jiang R, Cao M, Hao H, Jia R, Chen P, Liu Y
Front Endocrinol (Lausanne). 2023; 13:1079502.
PMID: 36601009
PMC: 9806261.
DOI: 10.3389/fendo.2022.1079502.
Anti-Müllerian hormone treatment enhances oocyte quality, embryonic development and live birth rate†.
Sinha N, Driscoll C, Qi W, Huang B, Roy S, Knott J
Biol Reprod. 2022; 107(3):813-822.
PMID: 35657015
PMC: 9476226.
DOI: 10.1093/biolre/ioac116.
The Predictive Value of the Follicular Output Rate on Pregnancy Outcome of Patients with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization and Embryo Transfer.
Yang H, Lin J, Jin C, Meng L, Wu S, Chen Y
Med Sci Monit. 2020; 26:e916175.
PMID: 33306667
PMC: 7737407.
DOI: 10.12659/MSM.916175.
Age-dependent changes in anti-Müllerian hormone levels in Lebanese females: correlation with basal FSH and LH levels and LH/FSH ratio: a cross-sectional study.
Racoubian E, Aimagambetova G, Finan R, Almawi W
BMC Womens Health. 2020; 20(1):134.
PMID: 32586307
PMC: 7318543.
DOI: 10.1186/s12905-020-00998-4.
Combinational approach of retrospective clinical evidence and transcriptomics highlight AMH superiority to FSH, as successful ICSI outcome predictor.
Kastora S, Triantafyllidou O, Kolovos G, Kastoras A, Sigalos G, Vlahos N
J Assist Reprod Genet. 2020; 37(7):1623-1635.
PMID: 32430730
PMC: 7376803.
DOI: 10.1007/s10815-020-01802-w.
Follicular output rate tends to improve clinical pregnancy outcomes in patients with polycystic ovary syndrome undergoing fertilization-embryo transfer treatment.
Tan X, Wen Y, Chen H, Zhang L, Wang B, Wen H
J Int Med Res. 2019; 47(10):5146-5154.
PMID: 31379237
PMC: 6833430.
DOI: 10.1177/0300060519860680.
Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?.
Wang S, Zhang Y, Mensah V, Huber 3rd W, Huang Y, Alvero R
J Ovarian Res. 2018; 11(1):60.
PMID: 30012195
PMC: 6048693.
DOI: 10.1186/s13048-018-0430-z.
Evaluation of ovarian function after hysterectomy with or without salpingectomy: A feasible study.
Behnamfar F, Jabbari H
J Res Med Sci. 2017; 22:68.
PMID: 28616055
PMC: 5461581.
DOI: 10.4103/jrms.JRMS_81_17.
Anti Mullerian Hormone: Ovarian response indicator in young patients receiving Long GnRH Agonist Protocol for Ovarian Stimulation.
Jamil Z, Fatima S, Rehman R, Alam F, Arif S
Pak J Med Sci. 2016; 32(4):944-9.
PMID: 27648045
PMC: 5017108.
DOI: 10.12669/pjms.324.10267.
Electroacupuncture for reproductive hormone levels in patients with diminished ovarian reserve: a prospective observational study.
Wang Y, Li Y, Chen R, Cui X, Yu J, Liu Z
Acupunct Med. 2016; 34(5):386-391.
PMID: 27177929
PMC: 5099178.
DOI: 10.1136/acupmed-2015-011014.
Is anti-Müllerian hormone associated with IVF outcomes in young patients with diminished ovarian reserve?.
Pereira N, Setton R, Petrini A, Lekovich J, Elias R, Spandorfer S
Womens Health (Lond). 2016; 12(2):185-92.
PMID: 26901454
PMC: 5375045.
DOI: 10.2217/whe.15.102.
Ovarian reserve in women of late reproductive age by the method of treatment of PCOS.
Beltadze K, Barbakadze L
Iran J Reprod Med. 2015; 13(5):263-8.
PMID: 26220826
PMC: 4515232.
Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.
Devine K, Mumford S, Wu M, DeCherney A, Hill M, Propst A
Fertil Steril. 2015; 104(3):612-19.e3.
PMID: 26049057
PMC: 4560955.
DOI: 10.1016/j.fertnstert.2015.05.017.
Is ABO blood type associated with ovarian stimulation response in patients with diminished ovarian reserve?.
Pereira N, Hutchinson A, Bender J, Lekovich J, Elias R, Rosenwaks Z
J Assist Reprod Genet. 2015; 32(6):985-90.
PMID: 25935137
PMC: 4491069.
DOI: 10.1007/s10815-015-0485-3.
The role of serum AMH and FF AMH in predicting pregnancy outcome in the fresh cycle of IVF/ICSI: a meta-analysis.
Yao L, Zhang W, Li H, Lin W
Int J Clin Exp Med. 2015; 8(2):1755-67.
PMID: 25932104
PMC: 4402751.